Pinned Tweet
Follow our progress in developing innovative treatments for #oxidativestress, a driver of blinding #eyediseases and other conditions. Currently, we are advancing our treatments for #retinitispigmentosa, #cataract, and cystinosis with key backing from @FightBlindness’ @RD_Fund 👁️
Understanding the realities of #visionloss is key to fighting for a more accessible world. @FightBlindness' Vision Viewer simulates how retinal diseases affect vision. Visit fightingblindness.org/sharey… and join us to honor the visually impaired community for #BlindnessAwarenessMonth.
#AAO2026 is underway!
As we develop #oxidativestress therapies for blinding eye diseases, we’re looking forward to connecting with the global #ophthalmology community and learning ways to collectively advance new approaches for patients.
Experience the impact at #AAO2026 in New Orleans, Oct. 9-12! Gain hands-on learning, connect with ophthalmologists worldwide, and celebrate New Orleans style at Illuminate.
Don’t miss your opportunity to save on registration before rates increase on Sept. 10: aao.org/register
#AAO #Ophthalmology
#WorldSightDay is about highlighting eye health and the important role it plays in preventing vision loss.
Join the millions who have made the pledge to #LoveYourEyes and contribute to a movement to preserve sight globally: iapb.world/make_a_pledge
#EyeHealth #VisionLoss
World Sight Day 2026 is only 100 days away!
On 8 Oct, #WorldSightDay puts the power of people at the heart of the campaign, stories, lived experiences and voices driving action for eye health.
Learn more: brnw.ch/21x3MtV
#LoveYourEyes #EveryStoryCounts #2030InSight
Attending #Euretina26?
Dr. Fred Chen is presenting an ePoster highlighting our clinical data in #RP associated with #UsherSyndrome.
Learn more: euretina.org
#USH #retina
Save the Date: #Euretina26: Oct. 1 – 4, 2026, in Vienna, Austria.
Dr. Fred Chen will present an ePoster highlighting our clinical data in #RP associated with #UsherSyndrome.
Learn more: euretina.org/
#USH #retina
Encouraging progress in #UsherSyndrome research. In a new research update, @FightBlindness highlights advances across the field, including our Phase 3 SLO-RP Preserve trial evaluating NPI-001 in people with RP associated with Usher syndrome.
Read more: fightingblindness.org/news/u…
Usher syndrome (#USH) is a leading cause of #deafblindness. For #UsherSyndrome Awareness Day we’re spotlighting this rare, inherited disease and the community surrounding it.
Learn more about Nacuity’s clinical program for #visionloss in USH patients: preservevisionstudy.com/
At #UnitedInVision, CCO Dr. Jami Kern sat down w/ @RaceVsBlindness to discuss our #oxidativestress clinical programs. 🎬: youtube.com/watch?v=v14X8xBA…
Thanks to @FightBlindness & @Retina_Int for hosting an event where we can hear directly from patients & families!
The first site in the SLO-RP Preserve Phase 3 #clinicaltrial is enrolling at the @RetinaFndation in Dallas, TX!
This global, confirmatory #clinicaltrial is evaluating NPI-001 for #RetinitisPigmentosa associated w/#UsherSyndrome. Learn more at preservevisionstudy.com.
Thanks to @DallasInnovates for highlighting our patent win for NPI-001 for the treatment of #retinitispigmentosa!
We’re proud to be among the Dallas-Fort Worth companies that helped make the region rank No. 9 for patent activity.
Read more ⬇️ dallasinnovates.com/patented…
Heading to #USH2026?
Join us at the @UsherCoalition USH Connections Conference, where our CCO & SVP, Jami Kern, will share an update on NPI-001 and participate in a research panel.
📍July 18 | 11:15 a.m. CDT
Learn more: usher-syndrome.org/ush2026/a…
We are proud to sponsor the @UsherCoalition USH Connections Conference 2026, taking place July 17-19 in Bloomington, MN. Our CCO & SVP, Jami Kern, will present an update on NPI-001 to treat #RetinitisPigmentosa due to USH. Learn more: usher-syndrome.org/ush2026/a…
This #DeafBlindAwarenessWeek, we recognize the strength and resilience of the #deafblind community and reflect on the challenges they face. We desire to create an accessible world for all. #DBAW26
Exciting news for the #InheritedRetinalDisease community! Thanks @RaceVsBlindness for helping advance gene-agnostic therapeutic approaches, including our clinical development efforts in #RetinitisPigmentosa, and to @FightBlindness and @RD_Fund for their commitment to patients.
The Foundation Fighting Blindness and the RD Fund has announced a $1 million commitment from A Race Against Blindness (RAB) to advance gene-agnostic therapeutic approaches for inherited retinal diseases.
Read more about RAB and their commitment at: bit.ly/4vkVq1Z
June is #CataractAwarenessMonth. #Cataracts remain a leading cause of blindness affecting ~65M people worldwide.
Our investigational intravitreal implant is designed to slow cataracts after vitrectomy and improve surgical outcomes. Learn more: nacuity.com/development-prog…
This week is #UnitedInVision 2026 in our home city of Fort Worth, TX, June 12-13, 2026.
Don’t miss Nacuity SVP & CCO Dr. Jami Kern presenting. Details: fightingblindness.org/vision…
We look forward to a weekend of hope, innovation, and connection!
The Nacuity leadership team joined the global #ARVO2026 eye & vision community to present and engage in scientific sessions and discussions w/ researchers and orgs like @FightBlindness on the future of vision science. We're inspired by the progress across eye and vision research!
Attending #ARVO2026? Don’t miss our poster on NPI-001 tablets targeting #OxidativeStress to treat #RetinitisPigmentosa associated with #UsherSyndrome.
📍 Poster #0632 🔬 Session 512 (IRD II) 🗓 May 7 | 8:00–9:45 AM
Join our SVP & CCO, Dr. Jami Kern, at the #ARVO2026 "Bench to Bedside” pre-session on May 2 | 8 am - 2:45 pm MT to learn about our clinical progress and the path to IND for NACA for #retinitispigmentosa in the US and Australia.
🔗 arvo.org/annual-meeting/prog…
On National #DNA Day, we recognize the genetic research that has advanced #InheritedRetinalDisease treatment. 🧬 Genetic testing plays an important role in helping patients understand their diagnosis to get the care they need. Read more: @FightBlindness: fightingblindness.org/geneti…


















